CNTX-4975: Clinical Trials

4 trials of CNTX-4975, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow CNTX-4975: new trials by email Literature Review of CNTX-4975 trials Research Report on CNTX-4975

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
CNTX-4975 - Morton's Neuroma
Phase 2CompletedCentrexion Therapeutics672015-12-012018-05-09
Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain
CNTX-4975, Placebo - Osteoarthritis
Phase 2CompletedCentrexion Therapeutics1752015-08-012017-08-08
A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
CNTX-4975, Placebo - Painful Intermetatarsal Neuroma (Morton's Neuroma)
Phase 2CompletedCentrexion Therapeutics1192014-10-012016-12-06
Safety and Tolerability of 4975 in the Treatment of Moderate to Severe Knee Pain Due to Osteoarthritis (OA)
CNTX-4975 - Osteoarthritis of the Knee
Phase 2CompletedCentrexion Therapeutics542007-08-012016-12-06

Conditions studied

Morton Neuroma (2)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)

Sponsors

Centrexion Therapeutics (4)

Countries

United States (4)

Top investigators

Shaun Comfort, MD, MBA (1)  ·  William C Houghton, MD (1)

Results publications

PMID 30888737